NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

North America Pain Management Drugs Market by Drug Class (Nsaids, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Non-narcotic Analgesics), Market by (Indication, Arthriticpain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Post-operative Pain, Migraine, Fibromyalgia) & by Geography.

Report Summary

Pain management essentially applies scientific steps for the reduction of pain. A wide spectrum of conditions is covered which includes neuropathic pain, sciatica, postoperative pain and many more. It is a rapidly growing medical specialty that takes a multi-disciplinary approach to treat all kinds of pain to provide patients with a better quality of life. The market for pain management drugs is growing rapidly mainly due to the geriatric population growth, who require medications to alleviate from joint pain and other chronic conditions they are liable to get diagnosed. The North American market is developing mainly due to favorable regulatory conditions that are pushing the market growth at 3.62% CAGR from 2019-2027.

The high consumption of pain medication is a major factor for market growth in North America in recent years. The economies of the United States and Canada are the major shareholders for the pain management drugs market in the region. Government initiative and support to reduce the use of opioid medication for pain medication in the US has driven the search for non-opioid drugs for handling pain, further driving the R&D for the pain management drug industry in the country. Even though there has recent usage of non-opioid drugs in Canada, it did not penetrate the market as much as opioid drugs have. So, more incentives for promoting effective pharmacological alternatives to opioids can significantly impact the opioid crisis and the management of pain in the country.

The major market players in the pain management drugs market in North America are GlaxoSmithKline, Purdue Pharma L.P., Acura Pharmaceuticals, Inc., Cipher Pharmaceuticals Inc., Daiichi Sankyo, Inc., Egalet Corp., Eli Lilly and Company, Abbott Laboratories, Hikma Pharmaceuticals PLC, Johnson & Johnson, Lupin Ltd., Pfizer, Inc., Merck & Co., Inc., Novartis and Insys Therapeutics, Inc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
RESEARCH METHODOLOGY
- SOURCES OF DATA
  - SECONDARY DATA
  - PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
  - OPIOIDS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUG CLASS
  - CANCER PAIN INDICATION IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE

MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
  - GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
  - THE RISE IN AWARENESS REGARDING THE SIDE-EFFECTS OF PAIN MEDICATION
  - RISE IN GERIATRIC POPULATION
- MARKET RESTRAINTS
  - ACCESSIBILITY OF ALTERNATIVE THERAPIES
  - INCREASE IN DRUG MISTREATMENT
- MARKET OPPORTUNITIES
  - TECHNOLOGICAL ADVANCEMENT
  - GROWTH POTENTIAL IN UNTAPPED ECONOMIES
- MARKET CHALLENGES
  - PATENT EXPIRATION

MARKET BY DRUG CLASS
- NSAIDS
- ANESTHETICS
- ANTICONVULSANTS
- ANTI-MIGRAINE AGENTS
- ANTIDEPRESSANTS
- OPIOIDS
- NON-NARCOTIC ANALGESICS
MARKET BY INDICATION
- ARTHRITIC PAIN
- NEUROPATHIC PAIN
- CANCER PAIN
- CHRONIC BACK PAIN
- POST-OPERATIVE PAIN
- MIGRAINE
- FIBROMYALGIA
KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
  - THREAT OF NEW ENTRANTS
  - THREAT OF SUBSTITUTE
  - BARGAINING POWER OF SUPPLIERS
  - BARGAINING POWER OF BUYERS
  - THREAT OF COMPETITIVE RIVALRY
- REGULATORY FRAMEWORK
- OPPORTUNITY MATRIX
- VALUE CHAIN ANALYSIS
- VENDOR LANDSCAPE
GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
  - THE UNITED STATES
  - CANADA

COMPETITIVE LANDSCAPE
- MARKET SHARE ANALYSIS
- COMPANY PROFILES
  - ABBOTT LABORATORIES
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - ACURA PHARMACEUTICALS, INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - CIPHER PHARMACEUTICALS INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - DAIICHI SANKYO, INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - EGALET CORP.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - ELI LILLY AND COMPANY
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - GLAXOSMITHKLINE
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - HIKMA PHARMACEUTICALS PLC
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - JOHNSON & JOHNSON
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - LUPIN LTD.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - PFIZER, INC.
    - COMPANY PROFILES
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - PURDUE PHARMA L.P.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - MERCK & CO., INC.
    - COMPANY PROFILES
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - NOVARTIS
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - INSYS THERAPEUTICS, INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES

TABLE LIST

TABLE 1 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

TABLE 2 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 3 NORTH AMERICA NSAIDS MARKET 2019-2027 ($ MILLION)

TABLE 4 NORTH AMERICA ANESTHETICS MARKET 2019-2027 ($ MILLION)

TABLE 5 NORTH AMERICA ANTICONVULSANTS MARKET 2019-2027 ($ MILLION)

TABLE 6 NORTH AMERICA ANTI-MIGRAINE AGENTS MARKET 2019-2027 ($ MILLION)

TABLE 7 NORTH AMERICA ANTIDEPRESSANTS MARKET 2019-2027 ($ MILLION)

TABLE 8 NORTH AMERICA OPIOIDS MARKET 2019-2027 ($ MILLION)

TABLE 9 NORTH AMERICA NON-NARCOTIC ANALGESICS MARKET 2019-2027 ($ MILLION)

TABLE 10 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 11 NORTH AMERICA ARTHRITIC PAIN MARKET 2019-2027 ($ MILLION)

TABLE 12 NORTH AMERICA NEUROPATHIC PAIN MARKET 2019-2027 ($ MILLION)

TABLE 13 NORTH AMERICA CANCER PAIN MARKET 2019-2027 ($ MILLION)

TABLE 14 NORTH AMERICA CHRONIC BACK PAIN MARKET 2019-2027 ($ MILLION)

TABLE 15 NORTH AMERICA POST-OPERATIVE PAIN MARKET 2019-2027 ($ MILLION)

TABLE 16 NORTH AMERICA MIGRAINE MARKET 2019-2027 ($ MILLION)

TABLE 17 NORTH AMERICA FIBROMYALGIA MARKET 2019-2027 ($ MILLION)

TABLE 18 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

TABLE 19 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 20 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 21 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 22 CANADA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 23 CANADA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

FIGURE LIST

FIGURE 1 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 2 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET SHARE BY DRUG CLASS 2018 & 2027 (%)

FIGURE 3 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NSAIDS 2019-2027 ($ MILLION)

FIGURE 4 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANESTHETICS 2019-2027 ($ MILLION)

FIGURE 5 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTICONVULSANTS 2019-2027 ($ MILLION)

FIGURE 6 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTI-MIGRAINE AGENTS 2019-2027 ($ MILLION)

FIGURE 7 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTIDEPRESSANTS 2019-2027 ($ MILLION)

FIGURE 8 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY OPIOIDS 2019-2027 ($ MILLION)

FIGURE 9 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NON-NARCOTIC ANALGESICS 2019-2027 ($ MILLION)

FIGURE 10 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET SHARE BY INDICATION 2018 & 2027 (%)

FIGURE 11 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ARTHRITIC PAIN 2019-2027 ($ MILLION)

FIGURE 12 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NEUROPATHIC PAIN 2019-2027 ($ MILLION)

FIGURE 13 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY CANCER PAIN 2019-2027 ($ MILLION)

FIGURE 14 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY CHRONIC BACK PAIN 2019-2027 ($ MILLION)

FIGURE 15 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY POST-OPERATIVE PAIN 2019-2027 ($ MILLION)

FIGURE 16 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY MIGRAINE 2019-2027 ($ MILLION)

FIGURE 17 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY FIBROMYALGIA 2019-2027 ($ MILLION)

FIGURE 18 PORTER’S FIVE FORCE MODEL

FIGURE 19 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 20 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 21 CANADA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 22 PAIN MANAGEMENT MARKET SHARE ANALYSIS 2017 (%)

Segmentation

GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
  - THE UNITED STATES
  - CANADA

MARKET BY DRUG CLASS
- NSAIDS
- ANESTHETICS
- ANTICONVULSANTS
- ANTI-MIGRAINE AGENTS
- ANTIDEPRESSANTS
- OPIOIDS
- NON-NARCOTIC ANALGESICS
MARKET BY INDICATION
- ARTHRITIC PAIN
- NEUROPATHIC PAIN
- CANCER PAIN
- CHRONIC BACK PAIN
- POST-OPERATIVE PAIN
- MIGRAINE
- FIBROMYALGIA